1-6 of 6
Authors: Mitsuhiro Akiyama
Sort by
Journal Article
Disease-specific expansion of CD29+IL-17RA+ T effector cells possessing multiple signalling pathways in spondyloarthritis
Mitsuhiro Akiyama and others
Rheumatology, Volume 62, Issue 3, March 2023, Pages 1296–1305, https://doi.org/10.1093/rheumatology/keac391
Published: 07 July 2022
Journal Article
Comment on: Persistence of circulating T-follicular helper cells after rituximab is associated with relapse of IgG4-related disease
Mitsuhiro Akiyama and Yuko Kaneko
Rheumatology, Volume 60, Issue 11, November 2021, Pages e412–e413, https://doi.org/10.1093/rheumatology/keab687
Published: 10 September 2021
Journal Article
Immunoglobulin G4–related disease and idiopathic multicentric Castleman’s disease: confusable immune-mediated disorders
Takanori Sasaki and others
Rheumatology, Volume 61, Issue 2, February 2022, Pages 490–501, https://doi.org/10.1093/rheumatology/keab634
Published: 07 August 2021
Journal Article
Comment on: HHV-8-negative multicentric Castleman disease patients with serological, histopathological and imaging features of IgG4-related disease
Mitsuhiro Akiyama and others
Rheumatology, Volume 60, Issue 2, February 2021, Pages e73–e75, https://doi.org/10.1093/rheumatology/keaa753
Published: 30 November 2020
Journal Article
Lymphadenopathy in IgG4-related disease: a phenotype of severe activity and poor prognosis, with eotaxin-3 as a new biomarker
Satoshi Takanashi and others
Rheumatology, Volume 60, Issue 2, February 2021, Pages 967–975, https://doi.org/10.1093/rheumatology/keaa648
Published: 07 November 2020
Journal Article
Follicular helper T cells in the pathogenesis of IgG4-related disease
Get access
Mitsuhiro Akiyama and others
Rheumatology, Volume 57, Issue 2, February 2018, Pages 236–245, https://doi.org/10.1093/rheumatology/kex171
Published: 28 April 2017
Advertisement intended for healthcare professionals
Advertisement intended for healthcare professionals